175 related articles for article (PubMed ID: 20150379)
1. Nuclear factor IA is expressed in astrocytomas and is associated with improved survival.
Song HR; Gonzalez-Gomez I; Suh GS; Commins DL; Sposto R; Gilles FH; Deneen B; Erdreich-Epstein A
Neuro Oncol; 2010 Feb; 12(2):122-32. PubMed ID: 20150379
[TBL] [Abstract][Full Text] [Related]
2. Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.
Chen KS; Bridges CR; Lynton Z; Lim JWC; Stringer BW; Rajagopal R; Wong KT; Ganesan D; Ariffin H; Day BW; Richards LJ; Bunt J
J Neurooncol; 2020 Jan; 146(1):41-53. PubMed ID: 31760595
[TBL] [Abstract][Full Text] [Related]
3. The role of FilGAP, a Rac-specific Rho-GTPase-activating protein, in tumor progression and behavior of astrocytomas.
Hara A; Hashimura M; Tsutsumi K; Akiya M; Inukai M; Ohta Y; Saegusa M
Cancer Med; 2016 Dec; 5(12):3412-3425. PubMed ID: 27790861
[TBL] [Abstract][Full Text] [Related]
4. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.
Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D
Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010
[TBL] [Abstract][Full Text] [Related]
6. A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.
Elsir T; Edqvist PH; Carlson J; Ribom D; Bergqvist M; Ekman S; Popova SN; Alafuzoff I; Ponten F; Nistér M; Smits A
Int J Cancer; 2014 Mar; 134(5):1123-31. PubMed ID: 24037901
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor (FGFR) 4 correlated with the malignancy of human astrocytomas.
Yamada SM; Yamada S; Hayashi Y; Takahashi H; Teramoto A; Matsumoto K
Neurol Res; 2002 Apr; 24(3):244-8. PubMed ID: 11958417
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
9. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma.
Matusan-Ilijas K; Behrem S; Jonjic N; Zarkovic K; Lucin K
Pathol Oncol Res; 2008 Sep; 14(3):293-8. PubMed ID: 18493866
[TBL] [Abstract][Full Text] [Related]
11. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas.
Tsai WC; Chen Y; Huang LC; Lee HS; Ma HI; Huang SM; Sytwu HK; Hueng DY
J Neurooncol; 2013 Sep; 114(3):281-90. PubMed ID: 23817808
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas.
Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Otsuka Y; Yamaguchi M; Ohnishi H; Ohtaki S; Noshiro S; Ookawa S; Mikami T; Mikuni N; Honmou O
J Neurosurg Sci; 2018 Jun; 62(3):239-244. PubMed ID: 28079349
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
[TBL] [Abstract][Full Text] [Related]
16. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase expression in pediatric high grade astrocytoma.
Liang ML; Ma J; Ho M; Solomon L; Bouffet E; Rutka JT; Hawkins C
J Neurooncol; 2008 May; 87(3):247-53. PubMed ID: 18193393
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics and survival of spinal cord astrocytomas.
Zhang YW; Chai RC; Cao R; Jiang WJ; Liu WH; Xu YL; Yang J; Wang YZ; Jia WQ
Cancer Med; 2020 Oct; 9(19):6996-7006. PubMed ID: 32777166
[TBL] [Abstract][Full Text] [Related]
19. Elevated citrate in pediatric astrocytomas with malignant progression.
Blüml S; Panigrahy A; Laskov M; Dhall G; Krieger MD; Nelson MD; Finlay JL; Gilles FH
Neuro Oncol; 2011 Oct; 13(10):1107-17. PubMed ID: 21771868
[TBL] [Abstract][Full Text] [Related]
20. Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis.
Watanabe Y; Yamasaki F; Kajiwara Y; Saito T; Nishimoto T; Bartholomeusz C; Ueno NT; Sugiyama K; Kurisu K
J Neurooncol; 2010 Dec; 100(3):449-57. PubMed ID: 20455002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
